Cartesian Therapeutics, Inc. (RNAC)
USD 16.92
(-7.59%)
USD 16.92
(-7.59%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 26 Million | 110.77 Million | 85.07 Million | 16.59 Million | 6.67 Million | 903 Thousand |
| Cost of Revenue | 1.55 Million | 2.03 Million | - | - | - | - |
| Gross Profit | 24.45 Million | 108.74 Million | 85.07 Million | 16.59 Million | 6.67 Million | 903 Thousand |
| Operating Expenses | 110.86 Million | 96.23 Million | 89.67 Million | 73.41 Million | 57.1 Million | 64.95 Million |
| Selling, General and Administrative Expenses | 40.58 Million | 23.86 Million | 20.93 Million | 18.91 Million | 14.36 Million | 17.26 Million |
| Research and Development Expenses | 71.83 Million | 72.37 Million | 68.73 Million | 54.5 Million | 42.74 Million | 47.68 Million |
| Other Expenses | - | 330 Thousand | 15 Thousand | 89 Thousand | - | - |
| Cost and Expenses | 112.42 Million | 96.23 Million | 89.67 Million | 73.41 Million | 59.13 Million | 65.92 Million |
| Operating Income | -86.41 Million | 14.53 Million | -4.59 Million | -56.82 Million | -52.45 Million | -65.02 Million |
| Interest Expense | 2.83 Million | 3.03 Million | 2.84 Million | 1.55 Million | 1.51 Million | 1.49 Million |
| Income Tax Expense | -19 Million | -609 Thousand | 15.96 Million | 1.64 Million | 1.85 Million | 1.00 |
| Earnings before Tax | -238.71 Million | 34.77 Million | -9.72 Million | -68.87 Million | -55.35 Million | -65.33 Million |
| Net Income | -219.71 Million | 35.37 Million | -25.68 Million | -68.87 Million | -55.35 Million | -65.33 Million |
| Earnings Per Share Basic | -42.49 | 7.33 | -6.74 | -20.42 | -36.46 | -87.55 |
| Earnings Per Share Diluted | -42.49 | 2.98 | -6.74 | -20.42 | -36.46 | -87.55 |
| Weighted Average Shares Outstanding | 5.17 Million | 4.82 Million | 3.81 Million | 3.37 Million | 1.51 Million | 746.3 Thousand |
| Weighted Average Shares Outstanding (Diluted) | 5.17 Million | 4.86 Million | 3.81 Million | 3.37 Million | 1.51 Million | 746.3 Thousand |
| Gross Margin | 0.94 | 0.98 | 1.00 | 1.00 | 1.00 | 1.00 |
| EBIT Margin | -9.04 | 0.15 | -0.04 | -3.37 | -7.55 | -70.93 |
| Profit Margin | -8.45 | 0.32 | -0.30 | -4.15 | -8.29 | -72.35 |
| EBITDA | -235.06 Million | 39.83 Million | -5.15 Million | -65.59 Million | -51.8 Million | -62.86 Million |
| Earnings Before Tax Margin | -3.32 | 0.13 | -0.05 | -3.42 | -7.86 | -72.01 |
| Breakdown | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 |
|---|---|---|---|---|---|---|
| Revenue | 5.84 Million | 26 Million | 8.26 Million | 6.55 Million | 5.24 Million | 5.93 Million |
| Cost of Revenue | 183 Thousand | 1.55 Million | 272 Thousand | 189 Thousand | 626 Thousand | 616 Thousand |
| Gross Profit | 5.65 Million | 24.45 Million | 7.99 Million | 6.36 Million | 4.62 Million | 5.32 Million |
| Operating Expenses | 18.7 Million | 112.42 Million | 44.59 Million | 19.61 Million | 23.88 Million | 24.31 Million |
| Selling, General and Administrative Expenses | 9.16 Million | - | 22.16 Million | 6.61 Million | 6.1 Million | 5.69 Million |
| Research and Development Expenses | 9.53 Million | - | 22.43 Million | 13 Million | 17.78 Million | 18.62 Million |
| Other Expenses | 508 Thousand | 691 Thousand | -62 Thousand | 253 Thousand | 245 Thousand | 255 Thousand |
| Cost and Expenses | 18.88 Million | 112.42 Million | 44.59 Million | 19.61 Million | 23.88 Million | 24.31 Million |
| Operating Income | -13.04 Million | -86.41 Million | -36.33 Million | -13.06 Million | -18.63 Million | -18.38 Million |
| Interest Expense | - | 2.83 Million | - | 1.27 Million | 752 Thousand | 808 Thousand |
| Income Tax Expense | 139.72 Thousand | -19 Million | -19 Million | 1.52 Million | 997 Thousand | 1.06 Million |
| Earnings before Tax | -56.82 Million | -238.71 Million | -196.65 Million | -9 Million | -11.38 Million | -21.66 Million |
| Net Income | -56.82 Million | -219.71 Million | -177.65 Million | -9 Million | -11.38 Million | -21.66 Million |
| Earnings Per Share Basic | -10.50 | - | -34.43 | -1.74 | -2.23 | -4.24 |
| Earnings Per Share Diluted | -10.50 | - | -34.43 | -1.74 | -2.23 | -4.24 |
| Weighted Average Shares Outstanding | 5.41 Million | 5.16 Million | 5.16 Million | 5.16 Million | 5.11 Million | 5.11 Million |
| Weighted Average Shares Outstanding (Diluted) | 5.41 Million | 5.16 Million | 5.16 Million | 5.16 Million | 5.11 Million | 5.11 Million |
| Gross Margin | 0.97 | 0.94 | 0.97 | 0.97 | 0.88 | 0.90 |
| EBIT Margin | -2.20 | - | -4.37 | -1.93 | -3.47 | -3.02 |
| Profit Margin | -9.73 | -8.45 | -21.49 | -1.37 | -2.17 | -3.65 |
| EBITDA | -12.86 Million | - | -36.12 Million | -12.62 Million | -18.21 Million | -17.92 Million |
| Earnings Before Tax Margin | -2.23 | -3.32 | -4.40 | -1.99 | -3.55 | -3.10 |
CHH
GAEX
8176
SDY
UREKA
UBIS